{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:18:43Z","timestamp":1787750323663,"version":"build-2784847793"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To compare the effects of topical treatments with and without beta-blockers on diurnal and nocturnal intraocular pressure (IOP), systemic blood pressure (BP), and ocular perfusion pressure (OPP) in patients with normal-tension glaucoma (NTG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      NTG patients followed at the Glaucoma Unit of the Department of Ophthalmology, Sakarya University Training and Research Hospital between 2020 and 2025 were retrospectively analyzed. Patients receiving beta-blocker-containing therapy (Group 2,\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 21) and nonbeta-blocker therapy (Group 1,\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 18) were included. Twenty-four-hour IOP and systolic\/diastolic BP (DBP) measurements were recorded, and OPP was calculated. Optical coherence tomography parameters and visual field tests were also evaluated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Patients using beta-blockers had significantly lower diurnal and nocturnal systolic BP (SBP) compared to the nonbeta-blocker group (P\n                      <jats:sub>1<\/jats:sub>\n                      = 0.012, P\n                      <jats:sub>2<\/jats:sub>\n                      = 0.048). No significant differences were observed in DBP between groups during diurnal and nocturnal periods (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>1<\/jats:sub>\n                      = 0.126,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>2<\/jats:sub>\n                      = 0.255). There were no significant differences between groups in 24-h mean IOP values or IOP fluctuation (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>1<\/jats:sub>\n                      = 0.590,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>2<\/jats:sub>\n                      = 0.753). Diurnal OPP was significantly lower in the beta-blocker group, while nocturnal OPP did not differ between groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>1<\/jats:sub>\n                      = 0.012,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>2<\/jats:sub>\n                      = 0.258). Ganglion cell\u2013inner plexiform layer thickness was higher in the nonbeta-blocker group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.012). No significant differences were observed in other structural or functional measurements (retinal nerve fiber layer,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.599; mean deviation,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.457; pattern standard deviation,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.805).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In NTG patients, beta-blocker use reduces diurnal SBP and diurnal OPP but has no significant effect on 24-h IOP or nocturnal OPP. These findings support the critical role of systemic hemodynamics and ocular perfusion in NTG progression and suggest that beta-blockers should be monitored carefully for OPP effects, especially in normotensive patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/joco.joco_336_25","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:00:44Z","timestamp":1782126044000},"page":"395-399","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Systemic Hemodynamics and Ocular Perfusion in Normal-Tension Glaucoma: Evaluation of Beta-Blocker Effect"],"prefix":"10.4103","volume":"37","author":[{"given":"K\u00fcbra","family":"\u00d6zata G\u00fcndo\u011fdu","sequence":"first","affiliation":[{"name":"Department of Ophtalmology, Sakarya University Education and Research Hospital, Sakarya, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilg\u00fcn","family":"\u00d6zkan Aksoy","sequence":"additional","affiliation":[{"name":"Department of Ophtalmology, Sakarya University Medical Education and Research Hospital, Sakarya, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seren Kaplan","family":"G\u00fcng\u00f6rd\u00fc","sequence":"additional","affiliation":[{"name":"Department of Ophtalmology, Sakarya University Medical Education and Research Hospital, Sakarya, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"R1-20260623","first-page":"563","article-title":"Normal-tension glaucoma: Pathogenesis and genetics","volume":"17","author":"Trivli","year":"2019","journal-title":"Exp Ther Med"},{"key":"R3-20260623","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1350-9462(02)00008-3","article-title":"The impact of ocular blood flow in glaucoma","volume":"21","author":"Flammer","year":"2002","journal-title":"Prog Retin Eye Res"},{"key":"R4-20260623","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ajo.2011.06.019","article-title":"The rate of progression and ocular perfusion pressure in the low-pressure glaucoma treatment study","volume":"152","author":"Quaranta","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"R5-20260623","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1167\/iovs.06-0615","article-title":"Circadian fluctuation of mean ocular perfusion pressure is a consistent risk factor for normal-tension glaucoma","volume":"48","author":"Choi","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-20260623","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000335978","article-title":"Low diastolic blood pressure is associated with the progression of normal-tension glaucoma","volume":"228","author":"Okumura","year":"2012","journal-title":"Ophthalmologica"},{"key":"R7-20260623","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/bjo.2003.032110","article-title":"Ocular blood flow alteration in glaucoma is related to systemic vascular dysregulation","volume":"88","author":"Emre","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"R8-20260623","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ophtha.2007.03.017","article-title":"Risk factors for incident open-angle glaucoma: The Barbados eye studies","volume":"115","author":"Leske","year":"2008","journal-title":"Ophthalmology"},{"key":"R9-20260623","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.survophthal.2012.05.003","article-title":"24-hour intraocular pressure and ocular perfusion pressure in glaucoma","volume":"58","author":"Quaranta","year":"2013","journal-title":"Surv Ophthalmol"},{"issue":"Suppl 1","key":"R10-20260623","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/S0039-6257(02)00322-3","article-title":"Medical treatment of normal tension glaucoma","volume":"47","author":"Hoyng","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"R11-20260623","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/13543776.2019.1665023","article-title":"Adrenergic agonists and antagonists as antiglaucoma agents: A literature and patent review (2013-2019)","volume":"29","author":"Nocentini","year":"2019","journal-title":"Expert Opin Ther Pat"},{"key":"R13-20260623","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0002-9394(99)00160-9","article-title":"Beta-blocker eyedrops and nocturnal arterial hypotension","volume":"128","author":"Hayreh","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R14-20260623","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/bs.podrm.2020.07.002","article-title":"Betaxolol: A comprehensive profile","volume":"46","author":"Al-Wadei","year":"2021","journal-title":"Profiles Drug Subst Excip Relat Methodol"},{"key":"R15-20260623","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3390\/ph16081172","article-title":"Pharmaceutical approaches to normal tension glaucoma","volume":"16","author":"Salvetat","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"R16-20260623","doi-asserted-by":"crossref","first-page":"e0140601","DOI":"10.1371\/journal.pone.0140601","article-title":"Effects of topical bimatoprost 0.01% and timolol 0.5% on circadian IOP, blood pressure and perfusion pressure in patients with glaucoma or ocular hypertension: A randomized, double masked, placebo-controlled clinical trial","volume":"10","author":"Oddone","year":"2015","journal-title":"PLoS One"},{"key":"R17-20260623","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1177\/112067211002000602","article-title":"Meta-analysis of timolol on diurnal and nighttime intraocular pressure and blood pressure","volume":"20","author":"Lee","year":"2010","journal-title":"Eur J Ophthalmol"},{"key":"R18-20260623","doi-asserted-by":"crossref","first-page":"e621","DOI":"10.1111\/aos.12740","article-title":"Nocturnal blood pressure in primary open-angle glaucoma","volume":"93","author":"Pillunat","year":"2015","journal-title":"Acta Ophthalmol"}],"container-title":["Journal of Current Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/joco.joco_336_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:24:36Z","timestamp":1787747076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/joco.joco_336_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/joco.joco_336_25","relation":{},"ISSN":["2452-2325"],"issn-type":[{"value":"2452-2325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"2025-12-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}